Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden
· Delayed Price · Currency is SEK 1.885
-0.010 (-0.53%)
At close: Mar 6, 2026
Sprint Bioscience AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 167.17 | 65.64 | 50.49 | 0.08 | 35.11 | Upgrade
|
| Other Revenue | - | 0.5 | 1.2 | - | -0.09 | Upgrade
|
| Revenue | 167.17 | 66.14 | 51.69 | 0.08 | 35.03 | Upgrade
|
| Revenue Growth (YoY) | 152.75% | 27.97% | 62171.08% | -99.76% | 82.48% | Upgrade
|
| Cost of Revenue | 13.08 | 28.34 | 8.7 | 12.93 | 10.44 | Upgrade
|
| Gross Profit | 154.09 | 37.8 | 42.99 | -12.85 | 24.59 | Upgrade
|
| Selling, General & Admin | 55.69 | 56.28 | 45.07 | 47.44 | 49.47 | Upgrade
|
| Other Operating Expenses | 0.04 | -0.67 | -1.21 | -0.29 | - | Upgrade
|
| Operating Expenses | 56.8 | 56.57 | 44.31 | 47.77 | 50.06 | Upgrade
|
| Operating Income | 97.29 | -18.77 | -1.32 | -60.62 | -25.47 | Upgrade
|
| Interest Expense | -6.21 | -0.04 | - | -0 | -0.27 | Upgrade
|
| Interest & Investment Income | 0.65 | 1.43 | 0.79 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.9 | 0.09 | 0.45 | 0.69 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 | Upgrade
|
| Pretax Income | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 | Upgrade
|
| Net Income | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 | Upgrade
|
| Net Income to Common | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 | Upgrade
|
| Shares Outstanding (Basic) | 93 | 70 | 70 | 42 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 70 | 70 | 42 | 29 | Upgrade
|
| Shares Change (YoY) | 34.07% | 0.01% | 65.98% | 45.85% | 71.85% | Upgrade
|
| EPS (Basic) | 0.99 | -0.26 | -0.01 | -1.43 | -0.87 | Upgrade
|
| EPS (Diluted) | 0.98 | -0.26 | -0.01 | -1.43 | -0.87 | Upgrade
|
| Free Cash Flow | 83.44 | -24.65 | 20.42 | -59.05 | -42.82 | Upgrade
|
| Free Cash Flow Per Share | 0.89 | -0.35 | 0.29 | -1.40 | -1.49 | Upgrade
|
| Gross Margin | 92.18% | 57.16% | 83.17% | - | 70.21% | Upgrade
|
| Operating Margin | 58.20% | -28.37% | -2.56% | -73031.32% | -72.70% | Upgrade
|
| Profit Margin | 54.88% | -27.63% | -0.85% | -72493.98% | -71.61% | Upgrade
|
| Free Cash Flow Margin | 49.91% | -37.27% | 39.50% | -71149.40% | -122.26% | Upgrade
|
| EBITDA | 98.37 | -17.81 | -0.88 | -60 | -24.88 | Upgrade
|
| EBITDA Margin | 58.84% | -26.93% | -1.70% | - | -71.02% | Upgrade
|
| D&A For EBITDA | 1.07 | 0.96 | 0.45 | 0.62 | 0.59 | Upgrade
|
| EBIT | 97.29 | -18.77 | -1.32 | -60.62 | -25.47 | Upgrade
|
| EBIT Margin | 58.20% | -28.37% | -2.56% | - | -72.70% | Upgrade
|
| Revenue as Reported | 167.65 | 67.44 | 54.32 | 0.45 | 35.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.